4,6-Dioxoheptanoic acid
SIGMA/D1415 - powder
Synonym: Succinylacetone
CAS Number: 51568-18-4
Empirical Formula (Hill Notation): C7H10O4
Molecular Weight: 158.15
MDL Number: MFCD00002797
Linear Formula: CH3COCH2COCH2CH2CO2H
Product Type: Chemical
| form | powder |
| InChI | 1S/C7H10O4/c1-5(8)4-6(9)2 |
| InChI key | WYEPBHZLDUPIOD-UHFFFAOYSA |
| lipid type | saturated FAs |
| mp | 66-67 °C (lit.) |
| Quality Level | 200 ![]() |
| SMILES string | CC(=O)CC(=O)CCC(O)=O |
| storage temp. | 2-8°C |
| Application: | 4,6-Dioxoheptanoic acid has been used: • as component of dendritic cell conditioning medium and in the inhibition of ALA dehydratase (ALAD) in dendritic cells(50) • as an inhibitor of heme biosynthesis in human mononuclear cells(51) and HeLa cells(52) • as a standard for the quantification of succinylacetone from Plasmodium falciparum cultures(53) |
| Biochem/physiol Actions: | 4,6-Dioxoheptanoic acid is an inhibitor of heme biosynthesis. It is a catabolic byproduct of tyrosine breakdown and inhibits δ-aminolevulinic acid (ALA) dehydratase enzyme. It is a potential marker for detecting tyrosinemia type I and is measured in dried blood spot of new borns. |
| Biochem/physiol Actions: | An inhibitor of heme biosynthesis |
| Packaging: | 1 g in glass bottle |
| Packaging: | 100, 500 mg in glass bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H315 - H319 - H335 |
| Precautionary statements | P261 - P264 - P271 - P280 - P302 + P352 - P305 + P351 + P338 |
| Hazard Codes | Xi |
| Risk Statements | 36/37/38 |
| Safety Statements | 26-36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| mp | 66-67 °C (lit.) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352211 |


